Delivery Order SPE2DE21D0007-SPE2D625F7R49
Award Date
3/20/25
Potential Completion Date
3/25/25
Potential Value
$2K
Federal Agency
Medical Supply Chain
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract, valued at $3,661.19, is for the delivery of anti-JKA bioclone diagnostic equipment. It is a fixed-price delivery order with economic price adjustments, with a performance period ending on March 13, 2025. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical...
This is a fixed-price delivery order contract awarded by the Medical Supply Chain, a defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,073.80 contract is for the supply of ANTI-JKB BIOCLONE 1X3ML, a critical medical diagnostic product. The contract has a January 30, 2025 completion date and does not utilize any set-aside designations, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture...
This federal contract award SPE2DE21D0007|SPE2D625F1A97, valued at $1,602.60, was issued by the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The contract is for the supply of SERA ANTI-JKA 1X5ML, a medical diagnostic product, with a period of performance through March 7, 2025. This is a delivery order contract with a fixed price and economic price adjustment pricing type. No set-aside designation...
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract is for the supply of Anti-A Bioclone 15x10ml, a critical medical diagnostic product, with a ceiling value of $1,832.54 and a period of performance through March 25, 2025. The contract is a fixed-price agreement with economic price adjustment and does not have a set-aside designation,...
This federal contract award, valued at $1,023.13, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc. The contract is for the delivery of 4564318845 - ANTI-JKB BIOCLONE 1X3ML. It is a Fixed Price with Economic Price Adjustment type contract with a period of performance from April 17, 2024 to April 22, 2024. Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturer that provides a range of diagnostic solutions,...
This is a $6,649.19 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc. by the Defense Logistics Agency Troop Support Medical. The order is for 4563527080 ANTI-JKA BIOCLONE 1X3ML, a medical product, with a completion date of February 7, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture manufacturer that provides a range of diagnostic solutions, reagents, and equipment to federal healthcare programs including the Department...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Defense Health Agency (DHA). The contract, valued at $2,156.03, is a Delivery Order for the supply of Anti-SM E Bioclone 1x5ml, a critical medical diagnostic product. The contract has a period of performance ending on February 18, 2025. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and manufacturer of goods based in Raritan, New Jersey. The...
This federal contract award to Ortho-Clinical Diagnostics, Inc., a self-certified HUBZone joint venture manufacturer, was issued by the Medical Supply Chain division of the Defense Logistics Agency. The $2,869.77 firm-fixed-price delivery order is for the supply of 150 ml bottles of Reagent Anti-D Bioclone, a critical medical reagent. The contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and...
This is a delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense agency. The contract has a ceiling value of $1,832.54 and is for the delivery of ANTI-B BIOCLONE 15X10ML medical supplies. It is a fixed-price contract with economic price adjustment and does not have any set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture...
This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical, a subcomponent of the Defense Health Agency, to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $3,988.40 fixed-price with economic price adjustment contract is for the delivery of 4564177392 ANTI-JKA BIOCLONE 1X3ML by April 10, 2024. Ortho-Clinical Diagnostics has provided medical equipment, reagents, consumables, and testing services to various federal agencies, including the...